516 related articles for article (PubMed ID: 16424193)
1. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
3. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
5. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
7. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Han B; Serra P; Amrani A; Yamanouchi J; Marée AF; Edelstein-Keshet L; Santamaria P
Nat Med; 2005 Jun; 11(6):645-52. PubMed ID: 15908957
[TBL] [Abstract][Full Text] [Related]
9. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
[TBL] [Abstract][Full Text] [Related]
10. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
Marée AF; Santamaria P; Edelstein-Keshet L
Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
12. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
13. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
14. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice.
Mariño E; Walters SN; Villanueva JE; Richards JL; Mackay CR; Grey ST
Eur J Immunol; 2014 Apr; 44(4):983-93. PubMed ID: 24435807
[TBL] [Abstract][Full Text] [Related]
15. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
[TBL] [Abstract][Full Text] [Related]
16. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
17. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
18. Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes.
Chee J; Ko HJ; Skowera A; Jhala G; Catterall T; Graham KL; Sutherland RM; Thomas HE; Lew AM; Peakman M; Kay TW; Krishnamurthy B
J Immunol; 2014 Jan; 192(2):572-80. PubMed ID: 24337380
[TBL] [Abstract][Full Text] [Related]
19. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
Diamond AS; Gill RG
J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
[TBL] [Abstract][Full Text] [Related]
20. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
